One or more of the required application components couldn’t be loaded. Please, refresh the page.

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 07 12:04PM ET
0.3400
Dollar change
-0.0500
Percentage change
-12.82%
HSDT - Stock Price Chart
Index- P/E- EPS (ttm)-5.76 Insider Own0.93% Shs Outstand6.13M Perf Week-15.21%
Market Cap2.08M Forward P/E- EPS next Y-0.35 Insider Trans0.00% Shs Float6.07M Perf Month-24.44%
Income-11.74M PEG- EPS next Q-0.58 Inst Own3.49% Short Float1.09% Perf Quarter-50.90%
Sales0.52M P/S4.01 EPS this Y85.22% Inst Trans97.01% Short Ratio0.03 Perf Half Y-35.95%
Book/sh0.28 P/B1.20 EPS next Y45.31% ROA-209.04% Short Interest0.07M Perf Year-94.47%
Cash/sh0.18 P/C1.91 EPS next 5Y- ROE-688.88% 52W Range0.37 - 6.79 Perf YTD-49.28%
Dividend Est.- P/FCF- EPS past 5Y63.29% ROI-1108.78% 52W High-94.99% Beta0.93
Dividend TTM- Quick Ratio1.10 Sales past 5Y-12.70% Gross Margin-16.54% 52W Low-8.11% ATR (14)0.05
Dividend Ex-Date- Current Ratio1.58 EPS Y/Y TTM59.74% Oper. Margin-2665.96% RSI (14)33.60 Volatility10.37% 8.98%
Employees21 Debt/Eq0.01 Sales Y/Y TTM-19.25% Profit Margin-2258.08% Recom1.00 Target Price4.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q28.55% Payout- Rel Volume0.11 Prev Close0.39
Sales Surprise52.00% EPS Surprise22.34% Sales Q/Q13.43% EarningsMar 13 Avg Volume2.54M Price0.34
SMA20-16.24% SMA50-31.02% SMA200-47.37% Trades Volume113,497 Change-12.82%
Date Action Analyst Rating Change Price Target Change
Mar-24-21Initiated Noble Capital Markets Outperform $20
Mar-13-25 07:00AM
Mar-11-25 07:00AM
Jan-22-25 07:00AM
Jan-21-25 08:00PM
07:00AM
07:00AM Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
Dec-23-24 07:00AM
Nov-18-24 08:01AM
08:00AM
Oct-18-24 08:00AM
Oct-14-24 05:00PM
Sep-30-24 08:00AM
Aug-16-24 05:00PM
Aug-12-24 04:05PM
Aug-06-24 04:36PM
Jun-28-24 06:00AM
07:00AM Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
Jun-17-24 07:00AM
Jun-06-24 07:38AM
07:00AM
May-31-24 12:30PM
May-29-24 09:00AM
May-23-24 09:00AM
May-20-24 09:00AM
May-13-24 08:53PM
04:05PM
May-10-24 09:00AM
May-08-24 07:31AM
May-07-24 07:39AM
May-06-24 10:15PM
09:00AM
May-03-24 08:12AM
07:31AM Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.Finviz Elite
07:31AM
Apr-24-24 09:05AM
Apr-03-24 07:05AM
Apr-01-24 12:18PM
Mar-28-24 04:05PM
Mar-15-24 07:05AM
Mar-12-24 08:59AM
Mar-07-24 07:00AM
Mar-04-24 07:00AM
Feb-06-24 07:00AM
Feb-05-24 07:05AM
Jan-11-24 07:00AM
Dec-07-23 09:55AM
Nov-30-23 07:47AM
Nov-13-23 11:07AM
Nov-09-23 04:05PM
Nov-06-23 07:05AM
Nov-02-23 05:05PM
Oct-20-23 02:34PM
Oct-12-23 07:05AM
Oct-02-23 07:05AM
Sep-28-23 07:00AM
Sep-21-23 07:05AM
Sep-20-23 07:05AM
Sep-13-23 07:05AM
Sep-06-23 09:55AM
Sep-05-23 07:00AM
Aug-16-23 09:00AM
Aug-13-23 08:13AM
Aug-11-23 07:33AM
Aug-10-23 06:15PM
04:05PM
Aug-07-23 07:05AM
Aug-02-23 04:05PM
Jul-27-23 07:05AM
Jun-20-23 07:05AM
Jun-14-23 04:05PM
May-25-23 07:05AM
May-24-23 07:05AM
May-19-23 05:00PM
May-16-23 12:14PM
May-12-23 06:31AM
May-11-23 04:05PM
May-04-23 04:05PM
Apr-17-23 07:05AM
Apr-16-23 06:30AM
Mar-24-23 12:29PM
Mar-23-23 05:00PM
Mar-22-23 07:05AM
Mar-10-23 06:22AM
Mar-09-23 04:05PM
07:05AM
Mar-06-23 07:30AM
Mar-02-23 04:05PM
Feb-15-23 07:05AM
Jan-23-23 07:05AM
Jan-19-23 09:00AM
Jan-10-23 07:05AM
Jan-05-23 07:41AM
Jan-03-23 07:05AM
Dec-30-22 04:05PM
Nov-17-22 12:00PM
Nov-14-22 06:30AM
Nov-09-22 07:05AM
Nov-08-22 07:05AM
Nov-03-22 07:05AM
Nov-01-22 07:05AM
Oct-13-22 07:05AM
Sep-29-22 05:20PM
Sep-14-22 05:05PM
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Income Statement Balance Sheet Cash Flow

Data

Timeframe

PeriodTTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period End Date12/31/202412/31/202312/31/202212/31/202112/31/202012/31/201912/31/2018
Period Length12 Months12 Months12 Months

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, historical statements, and much more.

Learn more
Total Revenue
0.520.520.64
Cost of Goods Sold Incl. D&A
0.610.640.74
Gross Profit
-0.09-0.12-0.10
Selling, General and Administrative Excl. Other
13.7813.7412.17
Research and Development
3.663.662.94
Other Operating Expense
0.000.000.00
Operating Income
-13.86-13.86-12.27
Interest Expense
0.000.000.00
Unusual Expense
-2.94-2.94-2.81
Net Income Before Taxes
-11.74-11.74-8.85
Income Taxes
0.000.000.00
Consolidated Net Income
-11.74-11.74-8.85
Net Income From Continuing Operations
-11.74-11.74-8.85
Net Income
-11.74-11.74-8.85
EPS (Recurring)
-3.70-5.09-17.79
EPS (Basic, Before Extraordinaries)
-5.76-4.33-14.56
EPS (Diluted)
-5.76-4.33-14.56
EBITDA
-13.80-13.80-12.11
Price To Earnings Ratio
-0.07-0.07-0.12
Price To Sales Ratio
4.813.497.59
Gross Margin
-16.54-23.46-15.68
Operating Margin
-2,665.96-2,665.96-1,905.12
Net Margin
-2,258.08-2,258.08-1,374.22
Shares Outstanding
3.733.730.71
Market Capitalization
2.392.392.67